Subscribe
shutterstock_1231106194_pajor_pawel
Pajor Pawel / Shutterstock.com
5 January 2023EuropeStaff Writer

Oxford University startup ordered to pay royalties

‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
1 February 2021   The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.
Big Pharma
Oxford University and Novo Nordisk invest $143m in diabetes partnership
30 January 2017   The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

article
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
1 February 2021   The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.
Big Pharma
Oxford University and Novo Nordisk invest $143m in diabetes partnership
30 January 2017   The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes.

More on this story

article
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
1 February 2021   The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.
Big Pharma
Oxford University and Novo Nordisk invest $143m in diabetes partnership
30 January 2017   The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility